Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Phio Pharmaceuticals Corp. | StockGist | StockGist

Companies
PHIO
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings PHIOSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Phio Pharmaceuticals Corp.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001533040

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Phio Pharmaceuticals Corp.

Person Type

CO

CUSIP: 71880W501

Amendment History

8 filings

SCHEDULE 13G
Original
Nov 10, 20250001649553-25-000206
SCHEDULE 13G/A
Amendment 1
Feb 7, 20250001649553-25-000039
SCHEDULE 13G/A
Amendment 2
Aug 7, 20250001641172-25-022581
SCHEDULE 13G/A
Amendment 3
Nov 7, 20250001213900-25-107723
SCHEDULE 13G/A
Amendment 4
Nov 12, 20250001493152-25-021629
SCHEDULE 13G/A
Amendment 5
Nov 24, 20250001493152-25-024820
SCHEDULE 13G/A
Amendment 6
Feb 13, 20260001213900-26-016522
SCHEDULE 13G/A
Amendment 7
Latest
Viewing
Feb 17, 20260001649553-26-000030

Recent Filings

Phio Pharmaceuticals Corp.4 days ago

Phio Pharmaceuticals Corp.4 weeks ago

Phio Pharmaceuticals Corp.4 weeks ago

Phio Pharmaceuticals Corp.1 months ago

Phio Pharmaceuticals Corp.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice